Company Filing History:
3 out of 207 
1 out of 377 
1 out of 23 Years Active: 2005-2014
Title: Marie Rosier: Innovator in Nuclear Factor Research
Introduction
Marie Rosier is a prominent inventor based in Antony, France. She has made significant contributions to the field of biomedical research, particularly in the area of nuclear factor kappa B (NFκB) and its implications in inflammation and disease.
Latest Patents
Marie Rosier holds five patents, with her latest inventions focusing on nuclear factor kappa B-inducing factor polypeptides (NFIF polypeptides). These polypeptides, including NFIF-14b and NFIF-7a, are capable of inducing NFκB. Her inventions encompass DNA, including cDNA, that encodes these polypeptides, as well as expression vectors for their expression. Additionally, her patents include methods and compositions for increasing or lowering NFκB induction in patients, methods for inhibiting inflammation, and the manufacture of medicaments aimed at treating or preventing NFκB-regulated inflammatory responses. Furthermore, she has developed methods for determining the effects of test compounds on the activity of NFIF polypeptides.
Career Highlights
Throughout her career, Marie Rosier has worked with notable companies such as Aventis Pharmaceuticals Inc. and Aventis Pharma S.A. Her work has significantly advanced the understanding of NFκB and its role in various inflammatory conditions.
Collaborations
Marie has collaborated with esteemed colleagues, including Patrice Denefle and Thomas F. Haws, contributing to her innovative research and development efforts.
Conclusion
Marie Rosier's work in the field of nuclear factor research has led to important advancements in understanding inflammation and its treatment. Her contributions continue to impact the biomedical field significantly.